{
    "clinical_study": {
        "@rank": "168168", 
        "arm_group": [
            {
                "arm_group_label": "PankoMab-GEX", 
                "arm_group_type": "Experimental", 
                "description": "1700mg, i.v., q3w"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "matching placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Efficacy of PankoMab-GEX vs Placebo in maintaining a response to chemotherapy in advanced\n      ovarian cancer."
        }, 
        "brief_title": "PankoMab-GEX\u2122 Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer", 
        "condition": "Epithelial Ovarian Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Neoplasms, Glandular and Epithelial"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is to evaluate the efficacy of PankoMab-GEX vs Placebo in maintaining response\n      after 2nd to 4th line of chemotherapy in patients with epithelial ovarian cancer. Patients\n      must have responded to platinum based chemotherapy in a previous line, while the response to\n      the most recent Pt-based chemotherapy must not have lasted more than 12 months. In addition\n      the response between most recent 2 lines of chemotherapy prior start of study medication\n      must not have lasted more than 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Female patients \u226518 years of age.\n\n          2. Histologically-confirmed, TA-MUC1 positive, recurrent epithelial ovarian carcinoma.\n\n          3. Availability of tumor tissue samples (slices or block) for immune-histological\n             confirmation of TA-MUC1 status (tissue samples may also be stored for other further\n             specified biomarker assessments).\n\n          4. Patients should have received at least 2 lines but not more than 5 lines of\n             chemotherapy prior to start of maintenance treatment.\n\n          5. Documented response to or stable disease following the most recent line of\n             chemotherapy (any regimen and duration in accordance with local or international\n             guidelines or within independent ethics committee [IEC] approved studies) and\n             received last dose of said chemotherapy \u22646 weeks prior to randomization (response to\n             prior chemotherapy is defined as a partial/complete response according to\n             radiological response criteria and/or a confirmed decline in tumor marker CA125 \u226550%\n             from the pretreatment value \u22652 \u00d7 the upper limit of normal [ULN]; stable disease is\n             defined as stable disease according to radiological response criteria with a\n             confirmed lack of increase in tumor marker CA125 from the pretreatment value for\n             patients who have a pretreatment value \u22652 \u00d7 ULN and no clinical progression). CA125\n             prior to randomization must be below ULN or CA125 levels must not increase >15%\n             within a time frame >7 days if above ULN.\n\n          6. Progression-free interval of \u226412 months immediately preceding the chemotherapy to\n             which the patient has just responded.\n\n          7. Sensitive or resistant to the most recent platinum-based chemotherapy preceding the\n             chemotherapy to which the patient has just responded (sensitive is thereby defined as\n             a recurrence of disease >6 to \u226412 months after end of platinum-based chemotherapy and\n             resistant is defined as a recurrence of disease \u22646 months after the end of\n             platinum-based chemotherapy).\n\n          8. ECOG performance status \u22641.\n\n          9. Recovered from all chemotherapy-related toxicities to grade 1 or grade 0 according to\n             the NCI CTCAE version 4.0, with the exception of alopecia (any grade) and peripheral\n             neuropathy (\u2264grade 2).\n\n         10. Adequate bone marrow and hepatic function at Screening:\n\n               -  Hemoglobin \u22659 g/dL\n\n               -  White blood cell count \u22653.0 \u00d7 109/L\n\n               -  Absolute neutrophil count \u22651.5 \u00d7 109/L\n\n               -  Platelet count \u2265100 \u00d7 109/L\n\n               -  Aspartate aminotransferase and alanine aminotransferase <3 \u00d7 ULN (<5 \u00d7 ULN in\n                  case of liver metastases)\n\n               -  Bilirubin <1.5 \u00d7 ULN (<3 \u00d7 ULN in case of liver metastases)\n\n               -  Creatinine <1.5 \u00d7 ULN.\n\n         11. Any patient with childbearing potential (i.e., not surgically sterile or\n             postmenopausal for >1 year) must use highly effective contraceptives with a Pearl\n             index <1% according to the Note for guidance on non-clinical safety studies for the\n             conduct of human clinical trials and marketing authorization for pharmaceuticals\n             (CPMP/ICH/286/95) of the European Medicines Agency (EMA) (Note: although pregnancy is\n             unlikely to occur in this patient population, any patient with childbearing potential\n             will be withdrawn from the study in the event of pregnancy).\n\n         12. Life expectancy >3 months.\n\n         13. Ability and willingness to give written informed consent.  -\n\n        Exclusion Criteria:\n\n          1. Refractory to platinum-based chemotherapy (defined as remained progressive or became\n             progressive under any previous platinum-based regimen).\n\n          2. Progression-free interval of >12 months after the most recent antecedent\n             platinum-based chemotherapy regimen.\n\n          3. Concomitant anti-tumor therapy or immunotherapy.\n\n          4. Treatment with monoclonal antibodies or investigational agents \u226430 days before\n             randomization (Note: prior anti-MUC1 therapy is not permitted at any time).\n\n          5. Limited-field radiotherapy \u226430 days before randomization (Note: extensive prior\n             radiotherapy during or following the last line of chemotherapy is not permitted;\n             radiotherapy prior to the last line of chemotherapy is permitted).\n\n          6. Prior allergic reaction to a monoclonal antibody, grade 3 IRR or any grade 4 reaction\n             to a monoclonal antibody.\n\n          7. Known sensitivity to any component of the test product.\n\n          8. Contraindication to the premedications used in this study (paracetamol/acetaminophen,\n             H1 and/or H2 receptor antagonists, and steroids).\n\n          9. Clinical evidence of brain metastasis or leptomeningeal involvement.\n\n         10. Patients with second primary cancer, except: adequately treated non-melanoma skin\n             cancer, curatively treated in-situ cancer of the cervix, Ductal Carcinoma in Situ\n             (DCIS), stage 1 grade 1 endometrial carcinoma, or other solid tumors including\n             lymphomas (without bone marrow involvement) curatively treated with no evidence of\n             disease for \u2265 5 years.\n\n         11. Primary or secondary immune deficiency.\n\n         12. Clinically active infections >grade 2 using NCI CTCAE v 4.0.\n\n         13. Active hepatitis B or C or infection with human immunodeficiency virus (HIV).\n\n         14. Myocardial infarction within 6 months prior to Screening.\n\n         15. Symptomatic congestive heart failure (New York Heart Association grade 3 or 4),\n             unstable angina pectoris within 6 months prior to Screening, significant cardiac\n             arrhythmia or history of stroke or transient ischemic attack within 1 year prior to\n             Screening.\n\n         16. Prior or planned major surgery within 30 days prior to randomization and/or\n             incomplete recovery from prior surgery.\n\n         17. Concomitant use of systemic steroids, except for inhaled, topical or nasal\n             application within 30 days prior to randomization (Note: steroids used for\n             premedication are permitted).\n\n         18. Active drug or alcohol abuse.\n\n         19. Any uncontrolled medical condition that may put the patient at high risk during\n             treatment with an investigational drug, including unstable diabetes mellitus, vena\n             cava syndrome, or chronic symptomatic respiratory disease.\n\n         20. Pregnancy or lactation.\n\n         21. Legal incompetence, limited legal competence, or detainment in an institution for\n             official or legal reasons.\n\n         22. Receipt of any other investigational medicinal product within the last 30 days before\n             randomization or any previous PankoMab-GEXTM administration."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899599", 
            "org_study_id": "GEXMab25201", 
            "secondary_id": "2013-000931-28"
        }, 
        "intervention": [
            {
                "arm_group_label": "PankoMab-GEX", 
                "intervention_name": "PankoMab-GEX", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "81675"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80337"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "zip": "91054"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stuttgart", 
                        "country": "Germany", 
                        "zip": "70376"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1088"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debrecen", 
                        "country": "Hungary", 
                        "zip": "4035"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pecs", 
                        "country": "Hungary", 
                        "zip": "7624"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Szeged", 
                        "country": "Hungary", 
                        "zip": "6720"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meldola", 
                        "country": "Italy", 
                        "zip": "47014"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy", 
                        "zip": "20133"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy", 
                        "zip": "20141"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00168"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bydgoszcz", 
                        "country": "Poland", 
                        "zip": "85796"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gdansk", 
                        "country": "Poland", 
                        "zip": "80402"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20090"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olsztyn", 
                        "country": "Poland", 
                        "zip": "10513"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poznan", 
                        "country": "Poland", 
                        "zip": "60569"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rzeszow", 
                        "country": "Poland", 
                        "zip": "35242"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brasov", 
                        "country": "Romania", 
                        "zip": "500091"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "010825"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cluj-Napoca", 
                        "country": "Romania", 
                        "zip": "400058"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cluj-Napoca", 
                        "country": "Romania", 
                        "zip": "400015"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Craiova", 
                        "country": "Romania", 
                        "zip": "200347"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oradea", 
                        "country": "Romania", 
                        "zip": "410469"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timisoara", 
                        "country": "Romania", 
                        "zip": "300239"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timisoara", 
                        "country": "Romania", 
                        "zip": "300167"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kazan", 
                        "country": "Russian Federation", 
                        "zip": "450029"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "115478"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "129128"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pyatigorsk", 
                        "country": "Russian Federation", 
                        "zip": "357502"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smolensk", 
                        "country": "Russian Federation", 
                        "zip": "214018"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "188663"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "198255"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "197758"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Volgograd", 
                        "country": "Russian Federation", 
                        "zip": "404133"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation", 
                        "zip": "150040"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08916"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28223"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46009"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "W1T 4TJ"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6JJ"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sutton", 
                        "country": "United Kingdom", 
                        "zip": "SM2 5PT"
                    }, 
                    "name": "Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Hungary", 
                "Italy", 
                "Poland", 
                "Romania", 
                "Russian Federation", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind, Placebo-controlled, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of Maintenance Therapy With PankoMab-GEX\u2122 After Chemotherapy in Patients With Recurrent Epithelial Ovarian Carcinoma", 
        "overall_contact": {
            "email": "frank.zimmermann@glycotope.com", 
            "last_name": "Frank Zimmermann, PhD", 
            "phone": "+49-309489", 
            "phone_ext": "2652"
        }, 
        "overall_official": {
            "affiliation": "UCL Cancer Institute, 90 Tottenham Court Road, London W1T 4TJ, UK", 
            "last_name": "Jonathan Ledermann, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Paul-Ehrlich-Institut", 
                "Hungary: National Institute for Quality and Organizational Development in Healthcare and Medicines", 
                "Italy: The Italian Medicines Agency", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Romania: National Agency for Medicines and Medical Devices", 
                "Russia: Ministry of Health of the Russian Federation", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "PFS will be determined by radiographic progression based on modified RECIST 1.1 or death of any cause.", 
            "measure": "Progression free survival", 
            "safety_issue": "No", 
            "time_frame": "from baseline till progression of disease or death"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899599"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Safety will be determined on the occurrence of infusion-related reactions (IRR, treatment emergent adverse events (TEAE) and treatment emergent serious adverse events (TESAE.", 
                "measure": "To assess the safety and tolerability of maintenance therapy with single-agent PankoMab-GEX\u2122 compared to placebo in patients with metastatic or recurrent ovarian carcinoma.", 
                "safety_issue": "Yes", 
                "time_frame": "3 weekly"
            }, 
            {
                "description": "To evaluate the quality of life (QoL) and other health and health-economy related outcomes", 
                "measure": "Patient reported outcome", 
                "safety_issue": "No", 
                "time_frame": "every 9 weeks"
            }
        ], 
        "source": "Glycotope GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Glycotope GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}